Switch to:
More From Other Websites
New incentives needed to develop antibiotics to fight superbugs May 27 2016
Gene therapy helping the blind to see May 27 2016
GSK gets EU approval for first gene therapy for children May 27 2016
GSK gets EU approval for first gene therapy for children May 27 2016
11:43 am GlaxoSmithKline: European Commission approves GSK's Strimvelis May 27 2016
StrimvelisTM receives European marketing authorisation to treat very rare disease, ADA-SCID May 27 2016
GSK gets EU approval for first gene therapy for children May 27 2016
Strimvelis receives EC marketing authorisation May 27 2016
Ionis Down, Glaxo Dumps IONIS-TTRRx Phase III Study Plans May 27 2016
Board and Committee changes May 27 2016
Lloyds Banking Group plc vs GlaxoSmithKline plc: which is the better growth stock? May 27 2016
There has never been a better time to buy GlaxoSmithKline plc, Persimmon plc and Admiral Group plc May 27 2016
Ionis Hits 3-Year Low As GlaxoSmithKline Drops Big Trial Plans May 26 2016
Ionis shares plummet as GSK scraps heart drug trial plans May 26 2016
[$$] Ionis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial May 26 2016
Why Ionis Pharmaceuticals (IONS) Stock Is Tanking Today May 26 2016
Ionis Pharmaceuticals Inc (IONS) Plunges After GSK Foregos Phase 3 Study of TTRRx May 26 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK